January 7, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the hospital’s participation in a nationwide NIH study examining a pair of monoclonal antibodies to treat COVID-19. The study is aimed at quickly identifying therapeutics worthy of larger clinical trials. Read: UTMC patients part of national study on COVID drugs
January 6, 2021
Experts from The University of Toledo will answer questions about the COVID-19 pandemic during a virtual town hall on Jan. 7. Read: UT to hold second coronavirus Town Hall online
January 6, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about hospital’s participation in a nationwide NIH study aimed at quickly and efficiently identifying additional therapeutics for COVID-19 worthy of larger clinical trials.
January 6, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the importance of developing new COVID-19 therapies and how UTMC is playing a role by participating in a nationwide NIH study of experimental treatments.
January 6, 2021
Experts from The University of Toledo will answer questions about the COVID-19 pandemic during a virtual town hall on Jan. 7. Read: UT hosting another virtual COVID-19 town hall
January 5, 2021
The proof-of-concept study is intended to quickly screen out ineffective experimental treatments while rapidly advancing the deployment of therapeutics that show significant benefit to hospitalized COVID-19 patients.
December 23, 2020
The event hosted by the University of Toledo Foundation is free and open to the public, though registration is required.
December 23, 2020
Ashleigh Konopka earned her master’s degree in public health from UToledo last spring and graduated in December with a master of science in occupational health.
December 22, 2020
UToledo researchers also say pandemic-related lockdowns have made it more difficult to identify and address child abuse.
December 17, 2020
All new and returning residential students will be scheduled for a no-cost rapid antigen test when arriving on campus.
